ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Bioenergetic Materials for Tissue Regeneration: Modulating Metabolism to Promote Cellular Anabolism.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tissue regeneration is an energy-demanding process that requires adequate ATP production to support cellular proliferation, biosynthesis, and tissue remodeling. Under pathological and age-related conditions, bioenergetic deficits impair intrinsic regenerative capacity by disrupting mitochondrial function, redox homeostasis, and anabolic signaling. Although conventional scaffold- and cell-based bioengineering strategies have advanced regenerative medicine, they generally do not directly address the metabolic dysfunction that limits tissue repair. Recently, bioenergetic materials (BEMs) have emerged as a novel class of biomaterials engineered to modulate cellular metabolism in situ. By supplying tricarboxylic acid (TCA) cycle intermediates, delivering metabolic enzymes, or incorporating oxygen-releasing and energy-harvesting components, BEMs replenish cellular ATP, restore redox balance, and activate anabolic signaling pathways that support tissue regeneration. In this review, we classify BEMs according to their principal mechanisms of action and summarize recent advances in their application to bone, cartilage, skin, and neural tissue repair. We further discuss the major challenges to clinical translation and highlight future opportunities for integrating metabolic modulation with advanced fabrication techniques and smart, feedback-regulated biomaterial systems. By reshaping the local metabolic microenvironments, BEMs represent a promising strategy to enhance tissue regeneration in pathological settings characterized by mitochondrial dysfunction, redox imbalance, inflammation, and insufficient energy supply.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.